دورية أكاديمية

Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection.

التفاصيل البيبلوغرافية
العنوان: Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection.
المؤلفون: Rizvi ZA; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India.; Immunology Core, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Dalal R; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Sadhu S; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Binayke A; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Dandotiya J; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Kumar Y; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Shrivastava T; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Gupta SK; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Aggarwal S; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Tripathy MR; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Rathore DK; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Yadav AK; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Medigeshi GR; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Pandey AK; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Samal S; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Asthana S; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Awasthi A; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India.; Immunology Core, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India.
المصدر: ELife [Elife] 2022 Jan 11; Vol. 11. Date of Electronic Publication: 2022 Jan 11.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Cambridge, UK : eLife Sciences Publications, Ltd., 2012-
مواضيع طبية MeSH: COVID-19*/blood , COVID-19*/complications , COVID-19*/pathology , Cardiovascular Diseases*/blood , Cardiovascular Diseases*/etiology , Cardiovascular Diseases*/pathology , Cardiovascular Diseases*/virology, SARS-CoV-2/*metabolism, Animals ; Cholesterol/blood ; Disease Models, Animal ; Female ; Humans ; Lipoproteins, LDL/blood ; Mesocricetus ; Triglycerides/blood ; Troponin I/blood
مستخلص: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the Golden Syrian hamster causes lung pathology that resembles human coronavirus disease (COVID-19). However, extrapulmonary pathologies associated with SARS-CoV-2 infection and post-COVID sequelae remain to be understood. Here, we show, using a hamster model, that the early phase of SARS-CoV-2 infection leads to an acute inflammatory response and lung pathologies, while the late phase of infection causes cardiovascular complications (CVCs) characterized by ventricular wall thickening associated with increased ventricular mass/body mass ratio and interstitial coronary fibrosis. Molecular profiling further substantiated our findings of CVC as SARS-CoV-2-infected hamsters showed elevated levels of serum cardiac troponin I, cholesterol, low-density lipoprotein, and long-chain fatty acid triglycerides. Serum metabolomics profiling of SARS-CoV-2-infected hamsters identified N-acetylneuraminate, a functional metabolite found to be associated with CVC, as a metabolic marker was found to be common between SARS-CoV-2-infected hamsters and COVID-19 patients. Together, we propose hamsters as a suitable animal model to study post-COVID sequelae associated with CVC, which could be extended to therapeutic interventions.
Competing Interests: ZR, RD, SS, AB, JD, YK, TS, SG, SA, MT, DR, AY, GM, AP, SS, SA, AA No competing interests declared
(© 2022, Rizvi et al.)
References: Cell Mol Life Sci. 2014 Feb;71(4):549-74. (PMID: 23649149)
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595. (PMID: 32571934)
Natl Sci Rev. 2020 Jul;7(7):1157-1168. (PMID: 34676128)
Nat Med. 2020 Nov;26(11):1694-1700. (PMID: 32884153)
J Am Heart Assoc. 2020 Apr 7;9(7):e016219. (PMID: 32233755)
Lancet Infect Dis. 2020 Sep;20(9):1015-1016. (PMID: 32304629)
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26955-26965. (PMID: 33037151)
Science. 2020 Mar 13;367(6483):1260-1263. (PMID: 32075877)
Nature. 2020 Mar;579(7798):183. (PMID: 32152596)
Curr Protoc Microbiol. 2020 Jun;57(1):ecpmc105. (PMID: 32475066)
Nat Commun. 2021 Jun 1;12(1):3182. (PMID: 34075041)
Front Immunol. 2021 Mar 31;12:648710. (PMID: 33868285)
Cardiovasc Drugs Ther. 2008 Apr;22(2):97-106. (PMID: 18253821)
J Biol Chem. 2020 Sep 4;295(36):12814-12821. (PMID: 32727845)
Science. 2020 Nov 13;370(6518):856-860. (PMID: 33082293)
Int J Obes (Lond). 2018 Aug;42(8):1406-1417. (PMID: 29795466)
Circ Res. 2016 Mar 18;118(6):1021-40. (PMID: 26987915)
Lancet. 2021 Jan 16;397(10270):173-175. (PMID: 33428868)
Vaccine. 2018 Mar 14;36(12):1627-1636. (PMID: 29429810)
Clin Sci (Lond). 2016 Apr 1;130(7):463-78. (PMID: 26888559)
Cell. 2020 Jun 25;181(7):1489-1501.e15. (PMID: 32473127)
Anal Chem. 2017 Aug 1;89(15):7933-7942. (PMID: 28641411)
Science. 2020 Nov 13;370(6518):861-865. (PMID: 33082294)
Oncotarget. 2018 Feb 9;9(17):13713-13732. (PMID: 29568389)
Science. 2020 May 29;368(6494):942-943. (PMID: 32467379)
Emerg Microbes Infect. 2020 Dec;9(1):2673-2684. (PMID: 33251966)
Analyst. 2018 Dec 17;144(1):220-229. (PMID: 30411762)
EBioMedicine. 2021 Jan;63:103154. (PMID: 33279860)
Immunol Rev. 2007 Jun;217:141-54. (PMID: 17498057)
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446. (PMID: 32215622)
Respir Res. 2000;1(2):93-108. (PMID: 11667972)
Lancet. 2021 Jan 16;397(10270):220-232. (PMID: 33428867)
Science. 2020 May 1;368(6490):473-474. (PMID: 32303591)
Cell. 2020 Nov 12;183(4):1058-1069.e19. (PMID: 33058755)
Oncotarget. 2018 Sep 28;9(76):34289-34305. (PMID: 30344943)
PLoS Pathog. 2021 Jul 15;17(7):e1009705. (PMID: 34265022)
Lancet Infect Dis. 2020 Jun;20(6):669-677. (PMID: 32240634)
Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L20-8. (PMID: 12730079)
Sci Rep. 2020 Jul 16;10(1):11824. (PMID: 32678274)
Lancet. 2020 Mar 21;395(10228):e52. (PMID: 32171074)
Nature. 2020 Jul;583(7818):834-838. (PMID: 32408338)
iScience. 2020 Oct 23;23(10):101645. (PMID: 33043283)
Lancet. 2020 Apr 25;395(10233):1339-1340. (PMID: 32304647)
Science. 2020 Aug 21;369(6506):956-963. (PMID: 32540903)
Circulation. 2018 Mar 27;137(13):1374-1390. (PMID: 29212895)
Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70. (PMID: 25969447)
Science. 2020 Sep 4;369(6508):. (PMID: 32669297)
Paediatr Respir Rev. 2017 Jun;23:40-49. (PMID: 28416135)
PLoS One. 2018 Dec 31;13(12):e0210116. (PMID: 30596774)
Nat Commun. 2017 Oct 9;8(1):815. (PMID: 28993609)
J Immunol. 2001 Apr 15;166(8):5208-18. (PMID: 11290805)
Signal Transduct Target Ther. 2020 Oct 15;5(1):240. (PMID: 33060566)
Nat Rev Immunol. 2020 Jun;20(6):339-341. (PMID: 32317716)
Science. 2020 May 29;368(6494):1016-1020. (PMID: 32269068)
Nat Commun. 2020 Nov 17;11(1):5838. (PMID: 33203860)
Brain Behav Immun. 2020 Jul;87:18-22. (PMID: 32240762)
Int J Infect Dis. 2020 Nov;100:327-332. (PMID: 32920235)
Drug Des Devel Ther. 2016 Sep 14;10:2929-2938. (PMID: 27695290)
J Am Coll Cardiol. 2020 Oct 27;76(17):2011-2023. (PMID: 33092737)
Trends Immunol. 2021 Jan;42(1):18-30. (PMID: 33277181)
Mucosal Immunol. 2020 Nov;13(6):877-891. (PMID: 32820248)
Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651)
Science. 2020 Jul 3;369(6499):50-54. (PMID: 32358202)
Viruses. 2020 Jul 20;12(7):. (PMID: 32698441)
Cell. 2020 Jul 9;182(1):59-72.e15. (PMID: 32492406)
Gut. 2020 Jul;69(7):1335-1342. (PMID: 32303609)
Sci Adv. 2021 Sep 10;7(37):eabg5016. (PMID: 34516769)
BMC Bioinformatics. 2017 Jul 10;18(1):331. (PMID: 28693421)
Nat Rev Cardiol. 2020 Sep;17(9):543-558. (PMID: 32690910)
mBio. 2020 Nov 12;11(6):. (PMID: 33184103)
Nat Med. 2020 May;26(5):681-687. (PMID: 32327758)
Cell Rep Med. 2020 Oct 20;1(7):100121. (PMID: 32984855)
JAMA Neurol. 2020 Jun 1;77(6):683-690. (PMID: 32275288)
Lancet Infect Dis. 2020 May;20(5):515-516. (PMID: 32213336)
Gastroenterology. 2020 May;158(6):1831-1833.e3. (PMID: 32142773)
فهرسة مساهمة: Keywords: SARS-CoV2; cardiovascular; hamster; infectious disease; microbiology
سلسلة جزيئية: Dryad 10.5061/dryad.vhhmgqnvt
المشرفين على المادة: 0 (Lipoproteins, LDL)
0 (Triglycerides)
0 (Troponin I)
97C5T2UQ7J (Cholesterol)
تواريخ الأحداث: Date Created: 20220111 Date Completed: 20220201 Latest Revision: 20220201
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8794466
DOI: 10.7554/eLife.73522
PMID: 35014610
قاعدة البيانات: MEDLINE
الوصف
تدمد:2050-084X
DOI:10.7554/eLife.73522